| XLS |
|
€ million |
Land, land-rights and buildings, including buildings on third-party land |
Plant and |
Other facilities, operating and office equipment |
Construction in progress and advance payments to vendors and contractors |
Total |
|
Acquisition cost January 1, 2008 |
1,754.9 |
2,325.3 |
760.2 |
187.4 |
5,027.8 |
|
Currency translation |
72.5 |
37.5 |
4.7 |
4.8 |
119.5 |
|
Changes in scope of consolidation |
– |
–2.4 |
1.4 |
0.2 |
–0.8 |
|
Additions |
25.2 |
44.6 |
46.4 |
278.5 |
394.7 |
|
Disposals |
–16.4 |
–80.8 |
–71.1 |
–4.1 |
–172.4 |
|
Transfers |
48.3 |
65.6 |
32.5 |
–151.2 |
–4.8 |
|
Reclassification of assets held for sale |
1.3 |
1.8 |
0.6 |
0.1 |
3.8 |
|
December 31, 2008 |
1,885.8 |
2,391.6 |
774.7 |
315.7 |
5,367.8 |
|
|
|
|
|
|
|
|
Accumulated depreciation |
–646.5 |
–1,544.4 |
–548.6 |
–13.8 |
–2,753.3 |
|
Currency translation |
–19.2 |
–32.3 |
–4.4 |
–0.4 |
–56.3 |
|
Changes in scope of consolidation |
–0.5 |
1.7 |
–1.6 |
–0.1 |
–0.5 |
|
Depreciation and impairment losses |
–68.4 |
–146.0 |
–62.5 |
–1.1 |
–278.0 |
|
Disposals |
13.9 |
76.7 |
67.9 |
0.1 |
158.6 |
|
Transfers |
0.4 |
0.4 |
2.1 |
– |
2.9 |
|
Write-ups |
0.4 |
0.5 |
0.1 |
– |
1.0 |
|
Reclassification of assets held for sale |
–0.5 |
–1.2 |
–0.4 |
– |
–2.1 |
|
December 31, 2008 |
–720.4 |
–1,644.6 |
–547.4 |
–15.3 |
–2,927.7 |
|
|
|
|
|
|
|
|
Net carrying amount |
1,165.4 |
747.0 |
227.3 |
300.4 |
2,440.1 |
|
|
|
|
|
|
|
|
Acquisition cost January 1, 2009 |
1,885.8 |
2,391.6 |
774.7 |
315.7 |
5,367.8 |
|
Currency translation |
0.8 |
3.0 |
1.5 |
2.6 |
7.9 |
|
Changes in scope of consolidation |
3.5 |
2.9 |
2.2 |
– |
8.6 |
|
Additions |
26.9 |
48.3 |
45.2 |
346.9 |
467.3 |
|
Disposals |
–60.5 |
–61.3 |
–52.3 |
–5.6 |
–179.7 |
|
Transfers |
37.7 |
71.0 |
33.6 |
–150.4 |
–8.1 |
|
December 31, 2009 |
1,894.2 |
2,455.5 |
804.9 |
509.2 |
5,663.8 |
|
|
|
|
|
|
|
|
Accumulated depreciation |
–720.4 |
–1,644.6 |
–547.4 |
–15.3 |
–2,927.7 |
|
Currency translation |
–1.2 |
–1.8 |
–1.3 |
– |
–4.3 |
|
Changes in scope of consolidation |
–0.4 |
–0.6 |
–0.3 |
– |
–1.3 |
|
Depreciation and impairment losses |
–73.7 |
–145.6 |
–66.3 |
– |
–285.6 |
|
Disposals |
54.1 |
57.1 |
46.5 |
4.8 |
162.5 |
|
Transfers |
0.2 |
–0.4 |
0.2 |
– |
– |
|
Write-ups |
0.1 |
– |
0.1 |
– |
0.2 |
|
December 31, 2009 |
–741.3 |
–1,735.9 |
–568.5 |
–10.5 |
–3,056.2 |
|
|
|
|
|
|
|
|
Net carrying amount |
1,152.9 |
719.6 |
236.4 |
498.7 |
2,607.6 |
Impairment losses totaled € 6.7 million in fiscal 2009. These were particularly attributable to impairment losses on production units in the Merck Serono and Performance & Life Science Chemicals divisions and are recorded under other operating expenses.
Property, plant and equipment amounting to € 8.1 million served as collateral (2008: € 9.1 million). Total government grants and subsidies during the fiscal year amounted to € 5.4 million (2008: € 7.1 million).
Property, plant and equipment also includes assets that are leased. The total value of capitalized leased assets amounted to € 13.0 million (2008: € 12.7 million) and the corresponding obligations amounted to € 10.4 million (2008: € 9.5 million) (see Note [25]).
The book values of capitalized leased assets were as follows:
| XLS |
|
€ million |
Dec. 31, 2009 |
Dec. 31, 2008 |
|
Capitalized leased buildings |
11.7 |
11.7 |
|
Capitalized leased vehicles |
1.1 |
0.8 |
|
Capitalized leased other property, plant and equipment |
0.2 |
0.2 |
|
|
13.0 |
12.7 |
back
